Post-approval studies (Phase 4)Study completedNCT02274792
What this trial is testing
Study to Assess the Immunogenicity and Safety of Etanercept Produced Using a Modified Process in Patients With Plaque Psoriasis
Who this might be right for
Plaque Psoriasis
Amgen 132